Huang Ying, Tarkhan Aliasghar
Fred Hutchinson Cancer Research Center, Seattle, WA 98109 USA.
Department of Biostatistics, University of Washington, Seattle, WA 98109 USA.
Stat Biosci. 2020;12(3):353-375. doi: 10.1007/s12561-020-09275-2. Epub 2020 Apr 15.
In clinical trials, it is often of interest to compare and order several candidate regimens based on multiple endpoints. For example, in HIV vaccine development, immune response profiles induced by vaccination are key for selecting vaccine regimens to advance to efficacy evaluation. Motivated by the need to rank and choose a few vaccine regimens based on their immunogenicity in phase I trials, Huang et al. (Biostatistics 18(2):230-243, 2017) proposed a ranking/filtering/selection algorithm that down-selects vaccine regimens to satisfy the superiority and non-redundancy criteria, based on multiple immune response endpoints. In practice, many candidate immune response endpoints can be correlated with each other. An important question that remains to be addressed is how to choose a parsimonious set of the available immune response endpoints to effectively compare regimens. In this paper, we propose novel algorithms for selecting immune response endpoints to be used in regimen down-selection, based on importance weights assigned to individual endpoints and their correlation structure. We show through extensive simulation studies that pre-selection of endpoints can substantially improve performance of the subsequent regimen down-selection process. The application of the proposed method is demonstrated using a real example in HIV vaccine research, although the methods are also applicable in general to clinical research for dimension reduction when comparing regimens based on multiple candidate endpoints.
在临床试验中,基于多个终点比较并排序几种候选治疗方案通常很有意义。例如,在HIV疫苗研发中,疫苗接种诱导的免疫反应谱是选择推进到疗效评估阶段的疫苗方案的关键。受在I期试验中根据免疫原性对几种疫苗方案进行排名和选择的需求驱动,Huang等人(《生物统计学》18(2):230 - 243,2017年)提出了一种排名/筛选/选择算法,该算法基于多个免疫反应终点向下选择疫苗方案,以满足优越性和非冗余标准。在实际中,许多候选免疫反应终点可能相互关联。一个有待解决的重要问题是如何选择一组简洁的可用免疫反应终点,以有效地比较治疗方案。在本文中,我们基于赋予各个终点的重要性权重及其相关结构,提出了用于选择在方案向下选择中使用的免疫反应终点的新算法。我们通过广泛的模拟研究表明,终点的预选可以显著提高后续方案向下选择过程的性能。使用HIV疫苗研究中的一个实际例子展示了所提出方法的应用,尽管这些方法一般也适用于基于多个候选终点比较治疗方案时进行降维的临床研究。